Roche’s Vabysmo lands clinical counterpunch in ophthalmology brawl with Eylea fkansteiner Thu, 10/27/2022 – 10:26 More: Roche's Vabysmo lands clinical counterpunch in ophthalmology brawl with Eylea Source: fierce
read moreUK only places 11th in terms of total R&D investment as a percentage of GDP More: UK lags behind other nations in research and development Source: News
read moreStudy involves patients with advanced common cancers and solid tumours More: Exelixis announces results from trial evaluating XB002 Source: News
read moreFDA keeps Jazz’s lung cancer accelerated approval in place—for now—despite failed trial and calls for withdrawal aliu Wed, 10/26/2022 – 14:20 More: FDA keeps Jazz's lung cancer accelerated approval in place—for now—despite failed trial and calls for withdrawal Source: fierce
read moreSanofi harnesses Dassault’s digital twin tech to optimize production at future vaccine plants fkansteiner Wed, 10/26/2022 – 12:03 More: Sanofi harnesses Dassault's digital twin tech to optimize production at future vaccine plants Source: fierce
read moreAiming to block Entresto generics, Novartis sues Mylan, Alembic and others for patent infringement zbecker Wed, 10/26/2022 – 11:07 More: Aiming to block Entresto generics, Novartis sues Mylan, Alembic and others for patent infringement Source: fierce
read more© 1994 - 2026 B.M. Pharmaceuticals